The majority of mutations are p53 missense mutations (mutp53) that have not only lost their tumor suppressor function, but often acquire broad oncogenic driver gain-of-function (GOF) activities promoting cancer progression, EMT, invasion, metabolism, metastasis, and chemoresistance14. This evidence concerns the gene TP53 and cancer.